tiprankstipranks
Gilead cuts FY24 adjusted EPS view to $3.45-$3.85 from $6.85-$7.25
PremiumThe FlyGilead cuts FY24 adjusted EPS view to $3.45-$3.85 from $6.85-$7.25
19d ago
Gilead reports Q1 adjusted EPS ($1.32), consensus ($1.39)
PremiumThe Fly
Gilead reports Q1 adjusted EPS ($1.32), consensus ($1.39)
19d ago
Gilead options imply 3.2% move in share price post-earnings
PremiumThe Fly
Gilead options imply 3.2% move in share price post-earnings
19d ago
Gilead price target lowered to $75 from $78 at Cantor Fitzgerald
PremiumThe FlyGilead price target lowered to $75 from $78 at Cantor Fitzgerald
22d ago
Options Volatility and Implied Earnings Moves This Week, April 22 – April 26, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves This Week, April 22 – April 26, 2024
22d ago
Unusually active option classes on open April 9th
PremiumThe Fly
Unusually active option classes on open April 9th
1M ago
Xilio Therapeutics, Gilead announce exclusive license agreement for XTX301
PremiumThe FlyXilio Therapeutics, Gilead announce exclusive license agreement for XTX301
2M ago
Xilio to get $43.5M upfront in pact with Gilead to develop/commercialize XTX301
PremiumThe Fly
Xilio to get $43.5M upfront in pact with Gilead to develop/commercialize XTX301
2M ago
Unusually active option classes on open March 22nd
PremiumThe Fly
Unusually active option classes on open March 22nd
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100